Only one study, regarding the possible prognostic role of SOX11 in MMs, was previously conducted (2013) by Jian et al. [25], on a smaller group of patients (n = 40) suggesting that SOX11 may be used for differential diagnosis of benign vs. malignant melanocytic tumors. This evidence concerns the gene SOX11 and cancer.